Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study

Kyung Mi Kim, Jin Huh, Soo Kyung Lee, Eun Young Park, Jung Min Lee, Hyo Ju Kim, Kyung Mi Kim, Jin Huh, Soo Kyung Lee, Eun Young Park, Jung Min Lee, Hyo Ju Kim

Abstract

Background: As a drug originally introduced for its anticonvulsant effects, gabapentin has been recently shown to be effective in the treatment of nausea and vomiting in various clinical settings. This study compared the antiemetic efficacy of oral gabapentin, intravenous ramosetron and gabapentin plus ramosetron in patients receiving fentanyl-based patient-controlled analgesia after laparoscopic gynecologic surgery.

Methods: One hundred and thirty two patients undergoing laparoscopic gynecologic surgery under general anesthesia were allocated randomly into three groups: group G received 300 mg oral gabapentin 1 h before anesthesia, group R received 0.3 mg intravenous ramosetron at the end of surgery, and group GR received a combination of 300 mg oral gabapentin 1 h before anesthesia and 0.3 mg intravenous ramosetron at the end of surgery. Postoperative nausea, retching, vomiting, rescue antiemetic drug use, pain, rescue analgesic requirements and adverse effects were assessed at 0-2, 2-24 and 24-48 h after surgery. Postoperative nausea and vomiting (PONV) was defined as the presence of nausea, retching or vomiting.

Results: The incidence of complete response (no PONV and no rescue antiemetics up to 48 h postoperatively) was significantly higher in group GR (26/40, 65%) than group G (16/40, 40%; P = 0.025) and group R (18/44, 41%; P = 0.027), whereas there was no significant difference between group G and group R (P = 0.932). There were no significant between-group differences in the incidence of emetic episodes, use of rescue antiemetics, severe emesis, use of rescue analgesics or any adverse effects. Postoperative pain scores were also similar among groups.

Conclusions: The combination with gabapentin and ramosetron is superior to either drug alone for prevention of PONV after laparoscopic gynecologic surgery.

Trial registration: ClinicalTrials.gov NCT02617121 , registered November 25, 2015.

Keywords: Gabapentin; Laparoscopic gynecologic surgery; Postoperative nausea and vomiting (PONV); Ramosetron.

Figures

Fig. 1
Fig. 1
CONSORT diagram showing the flow of participants in present study

References

    1. Myles PS, Williams DL, Hendrata M, Anderson H, Weeks AM. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth. 2000;84(1):6–10. doi: 10.1093/oxfordjournals.bja.a013383.
    1. Achuthan S, Singh I, Varthya SB, Srinivasan A, Chakrabarti A, Hota D. Gabapentin prophylaxis for postoperative nausea and vomiting in abdominal surgeries: a quantitative analysis of evidence from randomized controlled clinical trials. Br J Anaesth. 2015;114(4):588–597. doi: 10.1093/bja/aeu449.
    1. Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS, Gan TJ. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92(4):958–967. doi: 10.1097/00000542-200004000-00012.
    1. Habib AS, Chen YT, Taguchi A, Hu XH, Gan TJ. Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis. Curr Med Res Opin. 2006;22(6):1093–1099. doi: 10.1185/030079906X104830.
    1. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91(3):693–700. doi: 10.1097/00000542-199909000-00022.
    1. Ham SY, Shim YH, Kim EH, Son MJ, Park WS, Lee JS. Aprepitant for antiemesis after laparoscopic gynaecological surgery: a randomised controlled trial. Eur J Anaesthesiol. 2016;33(2):90–95. doi: 10.1097/EJA.0000000000000242.
    1. Lee WS, Lee KB, Lim S, Chang YG. Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial. BMC Anesthesiol. 2015;15:121. doi: 10.1186/s12871-015-0102-0.
    1. Joo J, Park YG, Baek J, Moon YE. Haloperidol dose combined with dexamethasone for PONV prophylaxis in high-risk patients undergoing gynecological laparoscopic surgery: a prospective, randomized, double-blind, dose–response and placebo-controlled study. BMC Anesthesiol. 2015;15:99. doi: 10.1186/s12871-015-0081-1.
    1. Gan TJ, Candiotti KA, Klein SM, Rodriguez Y, Nielsen KC, White WD, Habib AS. Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Can J Anaesth. 2009;56(11):829–836. doi: 10.1007/s12630-009-9175-x.
    1. Kim SH, Shin YS, Oh YJ, Lee JR, Chung SC, Choi YS. Risk assessment of postoperative nausea and vomiting in the intravenous patient-controlled analgesia environment: predictive values of the Apfel’s simplified risk score for identification of high-risk patients. Yonsei Med J. 2013;54(5):1273–1281. doi: 10.3349/ymj.2013.54.5.1273.
    1. Kranke P, Diemunsch P. The 2014 consensus guidelines for the management of postoperative nausea and vomiting: a leapfrog towards a postoperative nausea and vomiting-free hospital. Eur J Anaesthesiol. 2014;31(12):651–653. doi: 10.1097/EJA.0000000000000080.
    1. Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113. doi: 10.1213/ANE.0000000000000002.
    1. Rabasseda X. Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting. Drugs Today (Barc) 2002;38(2):75–89. doi: 10.1358/dot.2002.38.2.820104.
    1. Fujii Y. Current review of ramosetron in the prevention of postoperative nausea and vomiting. Curr Drug Saf. 2011;6(2):122–127. doi: 10.2174/157488611795684640.
    1. Lee YH, Seo JH, Min KT, Lim YJ, Jeong SW, Lee EK, Choi BM, Noh GJ. Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients. Br J Clin Pharmacol. 2016;82(3):762–772. doi: 10.1111/bcp.13010.
    1. Ryu JH, Lee JE, Lim YJ, Hong DM, Park HP, Han JI, Baik HJ, Kim HZ, Min KT, Do SH. A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron. BMC Anesthesiol. 2014;14:63. doi: 10.1186/1471-2253-14-63.
    1. Moore RA, Wiffen PJ, Derry S, McQuary HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Syst Rev. 2011;(3):CD007939.
    1. Chang CY, Challa CK, Shah J, Eloy JD. Gabapentin in acute postoperative pain management. Biomed Res Int. 2014;2014:631756.
    1. Cruz FM, de Iracema Gomes Cubero D, Taranto P, Lerner T, Lera AT, da Costa Miranda M, da Cunha Vieira M, de Souza Fede AB, Schindler F, Carrasco MM, et al. Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study. Support Care Cancer. 2012;20(3):601–606. doi: 10.1007/s00520-011-1138-4.
    1. Guttuso T., Jr Gabapentin’s anti-nausea and anti-emetic effects: a review. Exp Brain Res. 2014;232(8):2535–2539. doi: 10.1007/s00221-014-3905-1.
    1. Grant MC, Lee H, Page AJ, Hobson D, Wick E, Wu CL. The effect of preoperative gabapentin on postoperative nausea and vomiting: a meta-analysis. Anesth Analg. 2016;122(4):976–985. doi: 10.1213/ANE.0000000000001120.
    1. Ajori L, Nazari L, Mazloomfard MM, Amiri Z. Effects of gabapentin on postoperative pain, nausea and vomiting after abdominal hysterectomy: a double blind randomized clinical trial. Arch Gynecol Obstet. 2012;285(3):677–682. doi: 10.1007/s00404-011-2023-6.
    1. Heidari M, Honarmand A, Safavi M, Chitsazi M, Khalighinejad F. Geranisetron versus gabapentin in preventing postoperative nausea and vomiting after middle ear surgery in adults: a double-blinded randomized clinical trial study. Adv Biomed Res. 2015;4:22. doi: 10.4103/2277-9175.156654.
    1. Agrawal N, Chatterjee C, Khandelwal M, Chatterjee R, Gupta MM. Comparative study of preoperative use of oral gabapentin, intravenous dexamethasone and their combination in gynaecological procedure. Saudi J Anaesth. 2015;9(4):413–417. doi: 10.4103/1658-354X.159466.
    1. Park EY, Lee SK, Kang MH, Lim KJ, Kim YS, Choi E, Park YH. Comparison of ramosetron with combined ramosetron and midazolam for preventing postoperative nausea and vomiting in patients at high risk following laparoscopic gynaecological surgery. J Int Med Res. 2013;41(3):654–663. doi: 10.1177/0300060513487627.
    1. Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 2011;107(Suppl 1):i27–40. doi: 10.1093/bja/aer358.
    1. Apfel CC, Heidrich FM, Jukar-Rao S, Jalota L, Hornuss C, Whelan RP, Zhang K, Cakmakkaya OS. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):742–753. doi: 10.1093/bja/aes276.
    1. Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts JG. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology. 2003;98(1):46–52. doi: 10.1097/00000542-200301000-00011.
    1. Jahromi HE, Gholami M, Rezaei F. A randomized double-blinded placebo controlled study of four interventions for the prevention of postoperative nausea and vomiting in maxillofacial trauma surgery. J Craniofac Surg. 2013;24(6):e623–627. doi: 10.1097/SCS.0b013e3182a2d896.
    1. Eberhart LH, Morin AM, Bothner U, Georgieff M. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials. Acta Anaesthesiol Scand. 2000;44(10):1252–1257. doi: 10.1034/j.1399-6576.2000.441011.x.
    1. Ryu JH, Chang JE, Kim HR, Hwang JW, Oh AY, Do SH. Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: prospective, randomized, and double-blind study. Int J Surg (London, England) 2013;11(2):183–187. doi: 10.1016/j.ijsu.2012.12.018.
    1. Bhattarai B, Shrestha S, Singh J. Comparison of efficacy of Ondansetron and Dexamethasone combination and Ondansetron alone in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. J Pak Med Assoc. 2014;64(3):242–246.
    1. Stahl SM. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators. J Clin Psychiatry. 2004;65(8):1033–1034. doi: 10.4088/JCP.v65n0801.
    1. Guttuso T, Jr, Roscoe J, Griggs J. Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer. Lancet (London, England) 2003;361(9370):1703–1705. doi: 10.1016/S0140-6736(03)13365-X.
    1. Rychter J, Clave P. Intestinal inflammation in postoperative ileus: pathogenesis and therapeutic targets. Gut. 2013;62(11):1534–1535. doi: 10.1136/gutjnl-2012-304176.
    1. Pandey CK, Priye S, Ambesh SP, Singh S, Singh U, Singh PK. Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study. J Postgrad Med. 2006;52(2):97–100.
    1. Rose MA, Kam PCA. Gabapentin pharmacology and its use in pain management. Anesthesia. 2002;57:451–462. doi: 10.1046/j.0003-2409.2001.02399.x.
    1. White PF, O’Hara JF, Roberson CR, Wender RH, Candiotti KA, Group P-OS. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients. Anesth Analg. 2008;107(2):452–458. doi: 10.1213/ane.0b013e31817b842c.
    1. Kreis ME. Postoperative nausea and vomiting. Auton Neurosci. 2006;129(1–2):86–91. doi: 10.1016/j.autneu.2006.07.017.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner